These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30158581)

  • 1. The expression and function of RASAL2 in renal cell carcinoma angiogenesis.
    Hui K; Yue Y; Wu S; Gu Y; Guan B; Wang X; Hsieh JT; Chang LS; He D; Wu K
    Cell Death Dis; 2018 Aug; 9(9):881. PubMed ID: 30158581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
    Hui K; Wu S; Yue Y; Gu Y; Guan B; Wang X; Hsieh JT; Chang LS; He D; Wu K
    Cell Signal; 2018 Aug; 48():38-44. PubMed ID: 29702203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
    Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
    Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis.
    Zhang Y; Yang Y; Hu X; Wei B; Shen Q; Shi C; Chen P
    Transl Res; 2024 Jul; 269():14-30. PubMed ID: 38453052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
    Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
    Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
    PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
    Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
    Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.
    Hou P; Li H; Yong H; Chen F; Chu S; Zheng J; Bai J
    Angiogenesis; 2019 Nov; 22(4):507-519. PubMed ID: 31254127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.
    Huang J; Zhao X; Li X; Peng J; Yang W; Mi S
    PLoS Biol; 2021 Apr; 19(4):e3001197. PubMed ID: 33905408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
    Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
    Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
    Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
    Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
    Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
    Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
    Gobe GC; Ng KL; Small DM; Vesey DA; Johnson DW; Samaratunga H; Oliver K; Wood S; Barclay JL; Rajandram R; Li L; Morais C
    Biochem Biophys Res Commun; 2016 Apr; 473(1):47-53. PubMed ID: 26995091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.